Objective . To investigate vitamin D levels in patients with non-specifi c musculoskeletal pain, headache, and fatigue. Design . A cross-sectional descriptive study. Setting . A health center in Oslo, Norway, with a multi-ethnic population. Subjects . A total of 572 patients referred by a general practitioner (GP) for an examination of hypovitaminosis D who reported musculoskeletal pain, headache, or fatigue. The patients ' native countries were: Norway (n ϭ 249), Europe, America, and South-East Asia (n ϭ 83), and the Middle East, Africa, and South Asia (n ϭ 240). Both genders and all ages were included. 
Muscular pain, fatigue, and headache are common symptoms in general practice and have numerous and often non-specifi c etiologies. Hypovitaminosis D is a health problem worldwide and is frequently seen among immigrants in Norway [1, 2] . Although few systematic studies have been conducted regarding the relationships between vitamin D defi ciency and muscular pain, fatigue, and headache, these symptoms are found to be accompanied by vitamin D defi ciency in multi-ethnic patient populations and are amenable to treatment by vitamin D substitution [3 -5] .
Humans receive 80 -90% of their vitamin D supply through ultraviolet B sunlight exposure of the skin and the rest through vitamin D-containing foods [6 -8] . Only a few foods naturally contain vitamin D and vitamin D photoproduction is infl uenced by season, latitude of residence, and skin pigmentation. The elderly and people with dark skin need increased sunlight exposure time (twofold to 10-fold) for vitamin D synthesis compared with fair-skinned young individuals [8, 9] . Norway lies above the latitude that permits solar skin synthesis of vitamin D during the winter (4 -6 months) [9, 10] . In Norway, the consumption of cod liver oil during the winter months has been a decades-long tradition, as is enjoying sun exposure during the summer [11] . Many immigrants to Norway do not share these traditions, and therefore run a higher risk of vitamin D defi ciency [12] . Hypovitaminosis D is more common Vitamin D status in patients with musculoskeletal pain, fatigue and headache 167 among people who cover the body with protective clothing, those with dark skin pigmentation, who stay indoors and avoid direct sunlight, and among those with a low intake of fatty fi sh and cod liver oil [2, 8] .
Ultraviolet radiation (UV-B 290 -315nm) of the vitamin D precursor (7-dehyrocholesterol) in the skin photolyses it to previtamin D which is rapidly converted to vitamin D. Vitamin D becomes a steroid hormone after conversion to 25(OH)D 3 in the liver and is metabolized to the active 1,25(OH) 2 D 3 (calcitriol). This occurs mainly in the kidneys but also in various other tissues by 1 α -hydroxylase. Calcitriol is tightly regulated and shows only minimal variation. Activated vitamin D leads to multiple biological responses and regulates cell differentiation by binding to vitamin D receptors (VDR) in several body tissues [1, 6, 7, 13] . The fi nding of vitamin D receptors in human muscle in 2001 provides evidence of the importance of vitamin D for musculoskeletal function [14] . Treatment with vitamin D improved muscular function among patients with hypovitaminosis by increasing the cross-sectional area of fast-twitch type II A fi bers and improving proximal muscle strength [15, 16] . Correction of hypovitaminosis D reduced postural body sway and decreased the number of falls and fractures among geriatric patients [17] .
The best way to assess vitamin D status is to measure 25-hydroxyvitamin D [25(OH)D] in serum. The adequate range of 25(OH)D in Norway has been established at 50 -150 nmol/L. The optimal range of vitamin D is 75 -150 nmol/L and the amount of oral vitamin D intake needed to maintain a healthprotective effect remain, however, a matter of debate [1, 8, 9, 18] .
The aim of this cross-sectional descriptive study was to investigate levels of vitamin D among patients suffering from musculoskeletal pain, fatigue, or headache in a multi-ethnic population from a general practice in Norway. We hypothesized that a substantial proportion of patients with these symptoms would also have hypovitaminosis D, especially individuals with dark skin, a tradition of low sun exposure, and a low intake of food rich in vitamin D. We believe that our fi ndings will help inform the design and implementation of future intervention studies for hypovitaminosis D.
Material and methods
The study was conducted in a health center in which seven GPs serve 6200 registered patients in a multiethnic area in the north-eastern part of Oslo, Norway, at the latitude of 60 o N. In 2006, 33% of the population and 50% of children 0 -5 years in this part of Oslo were non-Western immigrants (Statistics Norway). In 2005 -2007, vitamin D levels were analyzed for 1729 patients, based on the doctors ' suspicion of low vitamin D intake and/or sun exposure. In 572 of these 1729 patients, the main reason for contact had been either headaches, local or general musculoskeletal pain, or fatigue. These 572 patients were included in the study. Vitamin D level was measured within two months of presentation, and had not been tested previously. Inclusion criteria were the following ICPC-2 (International Classifi cation of Primary Care, Second edition) diagnoses: headache (N01 and N95), local musculoskeletal pain (L01 -05, L08 -17, L83 -84, and L92), and general pain/fatigue (A01, A04, A29, L18 -20). Patients with osteoporosis, injury, intervertebral disc herniation, rheumatic disease, and migraine were not included.
Patient records were fully computerized. Automatic extracting procedures were applied to select patients into the study according to the inclusion criteria. Results of the selection process were manually verifi ed. Patient records for all 572 patients contained information on age, gender, ethnicity, serum vitamin D level (25(OH)D), and the time of year for the vitamin D test. The patients originated from 51 different countries (country of birth of the individual or their parents/mother) and were divided into three main geographic regions: (1) Norway, (2) Europe, America, and Southeast Asia, and (3) the Middle East, Africa, and South Asia. The geographic regions were selected based on the following major risk factors for vitamin D defi ciency: ethnic habits of covering the body, cultural food traditions, and the degree of skin pigmentation [8, 19] . Fasting blood samples were taken. Serums were consecutively sent to the same laboratory (F ü rst Medisinsk Laboratorium) for analysis by high-pressure liquid chromatography mass spectrometry (HPLC-MS results were received by modem. The assay laboratory is accredited by the International Organisation for Standardization.
Statistics and ethics
Bivariate comparisons were performed using independent sample t-tests (continuous variables) and chi-squared tests (categorical variables). Logistic regression analyses were performed to assess the impact of season, vitamin D level, gender, age, and region of origin (independent variables) on headache (dependent variable). Level of statistical signifi cance was set at 5% (p Ͻ 0.05). This study was approved by the Norwegian Social Science Data Service. The Directorate for Health and Social Affairs allowed a dispensation from the HealthProfessional Secrecy regulations. The Regional Committee for Research Ethics in Norway considered the study a quality assurance project not requiring formal approval because the study guaranteed the anonymity of patients.
Results
Descriptive characteristics of the 572 patients are illustrated in Table I . As seen from Table I , 71% of the patients were female. Patients from all geographic regions reported fatigue, widespread, general pain, or local pain more frequently than headache.
A total of 58% (334/572) patients had low vitamin D levels ( Ͻ 50 nmol/L, Table II ). According to region of origin, we found low vitamin D levels for 83% of patients from the Middle East, Africa, and South Asia, 58% for patients from Europe, America, and South-East Asia, and 35% for Norwegian patients. Among patients from the Middle East, Africa, and South Asia, women had a higher degree of hypovitaminosis D than men (less than 30 nmol/L: p ϭ 0.0005 and less than 25 nmol/L: p ϭ 0.021), and half of the women from this region had vitamin D levels below 25 nmol/L. Table III shows a signifi cant difference in mean vitamin D level between the three geographic regions, with the lowest level (32 nmol/L) in patients from the Middle East, Africa, and South Asia. Vitamin D levels were lower among patients presenting with headaches compared with other symptoms (Table III) . This fi nding was statistically signifi cant both in the total study population and in patients from Norway. Headache was still significantly associated with hypovitaminosis D (p ϭ 0.008, OR 2.6) after adjustment for gender, season, geographic region of origin, and age, as indicated by the logistic regression (data not shown). Some 15% (50/334) of patients with low ( Ͻ 50 nmol/L) vitamin D levels reported headache, compared with 5% (13/238) of those with adequate ( Ն 50 nmol/L) vitamin D levels (p Ͻ 0.001). Vitamin D levels showed a signifi cant correlation to age in the whole study population, but this result was affected by the lower mean age in the immigrant population (data not shown in table). Table IV shows the variation in vitamin D level throughout the year, with the lowest level in winter and early spring. Norwegians showed a higher increase in vitamin D level during summer and fall compared with patients from the Middle East, Africa, and South Asia.
Discussion
In this multi-ethnic patient population with musculoskeletal pain, headache, fatigue, and other clinical indicators warranting the examination of vitamin D level, 58% had vitamin D levels below the recommended level. Thus, results suggest that the GPs ' suspicion of hypovitaminosis D was frequently confi rmed. The lowest levels of vitamin D were found among patients complaining of headaches.
Our study is an exploratory, descriptive study, using existing data from a group general practice. It was therefore not specifi cally designed to investigate the relationships between the reported symptoms and vitamin D level, and results must be interpreted with caution. It is possible that the use of ICPC diagnostic labels may vary to some extent among the seven GPs. Headaches, however, are arguably less affected by such a bias than other types of diagnoses. To ensure a temporal link between the measured level of vitamin D and presenting complaint, a timeframe of two months or less was allotted. This time span was pragmatic, and a shorter time span may have enabled a stronger relationship, but fewer patients. A large decrease in vitamin D levels within the chosen time span was not expected, however, owing to the long half-life of vitamin D [15] .
Our fi ndings suggested an inverse relationship between headache and vitamin D, such that the frequency of headaches decreased with an increasing level of vitamin D. This association was equally present among men and women, indicating the significance for both genders. Moreover, the association was not eliminated in a regression model adjusting for age, gender, geographical region, and whether the analysis took place during winter or summer. Despite the limitations in our study design, we believe that the signifi cant relationship found between headache and vitamin D levels deserves further investigation. Existing literature on headache and hypovitaminosis D is sparse. However, a newly published case report showed substantial improvement in headaches within 4 -6 weeks following daily treatment with 1000 -1500IU cholecalciferol (D3) and calcium 1000 mg among eight patients with chronic tension headaches and a high degree of hypovitaminosis D [21] .
In our sample, a blood test was ordered by a GP due to suspected hypovitaminosis D. It was surprising to fi nd that the GPs ' suspicion was frequently confi rmed and, in particular, that 35% of ethnic Norwegians had hypovitaminosis D. Existing data suggest that vitamin D status is suffi cient among ethnic Norwegians [2] . In the Oslo Health Study 2000 -2001, only 14% of Norwegians aged 45 -75 years had vitamin D levels below 50 nmol/L, and the mean 25(OH)D was 75 nmol/L [22] . Based on our fi ndings, therefore, it appears that hypovitaminosis D among ethnic Norwegians is more frequent in our symptomatic study population than the general public. The high frequency of hypovitaminosis D among immigrants in our study corresponds with other studies [12] . Immigrants living in Norway report musculoskeletal pain more frequently than ethnic Norwegians, with immigrant women presenting with a higher frequency of complaints than men [23, 24] .
Vitamin D has an anti-infl ammatory effect through regulation of interleukin, tumor necrosis factor, and the activity of macrophages [1] . Thus, the supplementation of vitamin D might theoretically have a beneficial effect on infl ammatory induced pain. Treatment with vitamin D is shown to reduce pain among patients with diabetic polyneuropathies [25] . Data are as yet insuffi cient to support the hypothesis that vitamin D supplementation is useful in the treatment of chronic pain [26] . One study found, however, that musculoskeletal pain among Arab and IndoPakistani patients with hypovitaminosis D decreased (57) 128 (68) 13 (48) 22 (39) 13 (17) 27 ( (43) 60 (32) 14 (52) 34 (61) 65 (83) 135 (83) Ͻ 30nmol/L 7 (12) 13 (7) 6 (22) 11 (20) 35 (45) 105 (65) Ͻ 25nmol/L 3 (5) 11 (6) 5 (19) 5 (9) 25 (32) 79 (49) [4] . A study from the UK reported that chronic widespread pain among 3297 women was signifi cantly associated with vitamin D status. However, this association was not found among men [3] . A Danish study showed reduced muscular power in the proximal lower limb among Arab women with hypovitaminosis D compared with Danish controls. After treatment with vitamin D, however, their muscular power normalized [15] . The mean level of vitamin D in our study population varied signifi cantly during the year, as expected in a country located as far north as Norway [10, 27] . This variation was most prominent among Norwegian patients, while most patients from the Middle East, Africa, and South Asia had low vitamin D levels throughout the entire year. The minimal increase in vitamin D during the summer may be explained by avoidance of sun exposure and traditions of covering the body. The health consequences of a variable versus a chronically low vitamin D level remain unknown. However, recent studies have shown increased survival rates among cancer patients diagnosed in the seasons when vitamin D level is high [1, 28, 29] . Vitamin D inhibits tumor proliferation and promotes differentiation and apoptosis in numerous cell lines [28] . Several other health problems, such as cardiovascular disease, diabetes, and autoimmune diseases, have also recently been associated with vitamin D insuffi ciency [1, 6, 7, 8, 18] .
Findings from this study may alert doctors to the importance of inquiring about nutrition and sun exposure among patients reporting headache, musculoskeletal pain, and fatigue, and the value of referring these patients for the assessment of vitamin D levels. Whether the correction of vitamin D deficiency reduces symptom load is not fully established. Further studies are needed to examine whether correction of hypovitaminosis D increases the threshold for pain and fatigue and reduces headache. For personal use only.
